These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 34385796)

  • 1. Paraneoplastic Hyperfibrinolysis: Detection of Occult Prostate Cancer with 18F-Fluorodeoxyglucose Positron Emission Tomography-Computed Tomography.
    Sharma P
    Indian J Nucl Med; 2021; 36(2):203-204. PubMed ID: 34385796
    [TBL] [Abstract][Full Text] [Related]  

  • 2. More advantages in detecting bone and soft tissue metastases from prostate cancer using
    Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
    Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Whole-body
    Gajjala SR; Hulikal N; Kadiyala S; Kottu R; Kalawat T
    Indian J Med Res; 2018 Mar; 147(3):256-262. PubMed ID: 29923514
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Predictive Value of 18F-Fluorodeoxyglucose Positron Emission Tomography or Positron Emission Tomography/Computed Tomography for Assessment of Occult Lymph Node Metastasis in Non-Small Cell Lung Cancer.
    Seol HY; Kim YS; Kim SJ
    Oncology; 2021; 99(2):96-104. PubMed ID: 32980838
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical Relevance of Incidental Prostatic Lesions on FDG-Positron Emission Tomography/Computerized Tomography-Should Patients Receive Further Evaluation?
    Reesink DJ; Fransen van de Putte EE; Vegt E; De Jong J; van Werkhoven E; Mertens LS; Bex A; van der Poel HG; van Rhijn BW; Horenblas S; Meijer RP
    J Urol; 2016 Apr; 195(4 Pt 1):907-12. PubMed ID: 26598424
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prospective study of [18F]fluorodeoxyglucose positron emission tomography and computed tomography and magnetic resonance imaging in oral cavity squamous cell carcinoma with palpably negative neck.
    Ng SH; Yen TC; Chang JT; Chan SC; Ko SF; Wang HM; Lee LY; Kang CJ; Wong AM; Liao CT
    J Clin Oncol; 2006 Sep; 24(27):4371-6. PubMed ID: 16983105
    [TBL] [Abstract][Full Text] [Related]  

  • 7.
    Harlos C; Metser U; Poon R; MacCrostie P; Mason W
    Curr Oncol; 2019 Aug; 26(4):e458-e465. PubMed ID: 31548813
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prostate cancer with lytic bone metastases: 18F-fluorodeoxyglucose positron emission tomography-computed tomography for diagnosis and monitoring response to medical castration therapy.
    Sharma P; Karunanithi S; Singh Dhull V; Jain S; Bal C; Kumar R
    Indian J Nucl Med; 2013 Jul; 28(3):178-9. PubMed ID: 24250030
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased Prostate Cancer Glucose Metabolism Detected by
    Lavallée E; Bergeron M; Buteau FA; Blouin AC; Duchesnay N; Dujardin T; Tiguert R; Lacombe L; Fradet V; Makao-Nguile M; Fradet Y; Beauregard JM; Pouliot F
    Eur Urol Focus; 2019 Nov; 5(6):998-1006. PubMed ID: 29609897
    [TBL] [Abstract][Full Text] [Related]  

  • 10.
    Bae MR; Roh JL; Kim JS; Lee JH; Cho KJ; Choi SH; Nam SY; Kim SY
    J Cancer Res Clin Oncol; 2020 Jan; 146(1):237-244. PubMed ID: 31606761
    [TBL] [Abstract][Full Text] [Related]  

  • 11.
    Öztürk H; Karapolat I
    Oncol Lett; 2016 Jan; 11(1):316-322. PubMed ID: 26870210
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 11C-Choline and 18F-FDG PET/CT in the Detection of Occult Prostate Cancer in the Context of a Paraneoplastic Syndrome.
    Jiménez-Bonilla J; Quirce R; Banzo I; Martínez-Rodríguez I; Carril JM
    Clin Nucl Med; 2015 Aug; 40(8):695-6. PubMed ID: 26018697
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Incidental abnormal FDG uptake in the prostate on 18-fluoro-2-deoxyglucose positron emission tomography-computed tomography scans.
    Kang PM; Seo WI; Lee SS; Bae SK; Kwak HS; Min K; Kim W; Kang DI
    Asian Pac J Cancer Prev; 2014; 15(20):8699-703. PubMed ID: 25374193
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 18F-Fluorodeoxyglucose Positron Emission Tomography/Magnetic Resonance in Lymphoma: Comparison With 18F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography and With the Addition of Magnetic Resonance Diffusion-Weighted Imaging.
    Giraudo C; Raderer M; Karanikas G; Weber M; Kiesewetter B; Dolak W; Simonitsch-Klupp I; Mayerhoefer ME
    Invest Radiol; 2016 Mar; 51(3):163-9. PubMed ID: 26784400
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Selective Use of (18)F-Fluorodeoxyglucose-Positron Emission Tomography and Computed Tomography in the Management of Metastatic Disease from Colorectal Cancer: Results from a regional centre.
    Jafferbhoy S; Chambers A; Mander J; Paterson H
    Sultan Qaboos Univ Med J; 2015 Feb; 15(1):e52-7. PubMed ID: 25685386
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical Significance of
    Makis W; Ciarallo A
    Mol Imaging Radionucl Ther; 2017 Jun; 26(2):76-82. PubMed ID: 28613200
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Incidental detection of prostate-specific antigen-negative metastatic prostate cancer initially presented with solitary pulmonary nodule on fluorodeoxyglucose positron emission tomography/computed tomography.
    Erdogan EB; Buyukpinarbasili N; Ziyade S; Akman T; Turk HM; Aydin M
    Indian J Nucl Med; 2015; 30(3):268-71. PubMed ID: 26170575
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Can
    Gupta M; Datta A; Choudhury PS; Dsouza M; Batra U; Mishra A
    World J Nucl Med; 2017; 16(2):133-139. PubMed ID: 28553180
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of 18F-Fluorodeoxyglucose Positron Emission Tomography or Positron Emission Tomography/Computed Tomography for the Detection of Recurrent Disease after Treatment of Malignant Melanoma.
    Lee JW; Nam SB; Kim SJ
    Oncology; 2019; 97(5):286-293. PubMed ID: 31437839
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Value of [11C]choline-positron emission tomography for re-staging prostate cancer: a comparison with [18F]fluorodeoxyglucose-positron emission tomography.
    Picchio M; Messa C; Landoni C; Gianolli L; Sironi S; Brioschi M; Matarrese M; Matei DV; De Cobelli F; Del Maschio A; Rocco F; Rigatti P; Fazio F
    J Urol; 2003 Apr; 169(4):1337-40. PubMed ID: 12629355
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.